mosaiques diagnostics and therapeutics AG
About mosaiques diagnostics
The mosaiques diagnostics & therapeutics AG was established in Hannover (Germany). The company's core competence is the early and reliable detection of diseases enabling personalized medicine during therapy and drug development. The company utilizes diagnostic polypeptide patterns (DiaPat® Tests) derived from the fast and accurate analysis of proteins and polypeptides in body fluids (e.g. urine and cerebrospinal fluid). For this purpose, mosaiques has developed a unique technology on the basis of clinical proteome analysis, enabling the early and differential detection of cardiovascular, renal, and urogenital diseases. Diagnosis of bladder and prostate cancer, chronic renal diseases, diabetic nephropathy, graft-versus-host disease, ureteropelvic junction obstruction in newborn, and infarct risk is already marketed in Germany through the subsidiary DiaPat GmbH.
- Founding: 2002
- Focus : Manufacturer
- Employees: 11-50
- Industry : Diagnostics
News about mosaiques diagnostics
Here you will find mosaiques diagnostics and therapeutics AG
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
